Pull to refresh
Retatrutide 20mg research specimen

Specimen / RTA-2412-B2

Metabolism compound

Retatrutide 20mg

Retatrutide 20mg — triple GIP/GLP-1/glucagon receptor agonist research standard.

$65.005 in stock
1

Add 4 more to unlock Bulk (10% off)

For qualified laboratory research only. Not for human consumption.

How it's used

In plain terms.

This compound is used in laboratory settings to study metabolic processes and triple-receptor hormonal signaling pathways at increased concentrations.

What to expect

The experience.

Retatrutide is a triple-agonist peptide that targets multiple receptors related to metabolism and appetite. It is currently being studied for its potent effects on weight management and blood sugar control, offering researchers a new way to explore how these pathways can be regulated in tandem.

Clinical research vectors

Signals under study.

Studied for how it activates three distinct metabolic signaling receptors simultaneously in laboratory models.
Research focuses on triple-agonist pathways that regulate energy intake, glucose processing, and lipid metabolism.
Used in controlled laboratory settings to observe dose-dependent changes in metabolic signaling efficiency.

Analytical record

Molecular formula
C240H386N52O66
Molecular weight
4776.2 g/mol
Lot
RTA-2412-B2
Batch
AEB-KOPQXA
Purity
≥ 99.0%
Validation
Third-party HPLC verified

Certificate data shown for catalog demonstration. Verify the lot-specific certificate before research use.

Protocol planner

Estimate your monthly protocol.

Project monthly consumption based on target dosing frequency. Figures are research-use estimates, not medical guidance.

3
114
250
502000
2000
50010000
Doses / month13
Total / month3.26 mg
Vials needed2
Est. monthly cost$130.00

Based on 4.345 weeks/month. Rounded up to whole vials. Verify against certificate of analysis before reconstitution.

Field notes

Researcher reviews.

0.0
0 reviews

Leave a review

Loading…

Synergetic stack / model 01

Molecular bridges.